Baran A. Ersoy, Ph.D.
Affiliations: | 2009 | Pharmaceutical Sciences and Pharmacogenomics | University of California, San Francisco, San Francisco, CA |
Area:
Genetics of ObesityGoogle:
"Baran Ersoy"Mean distance: 42746.4
Parents
Sign in to add mentor| Christian Vaisse | grad student | 2009 | UCSF | |
| (Deciphering the melanocortin system: Three distinct approaches.) | ||||
| David Cohen | post-doc | Massachusetts General Hospital and Harvard Medical School | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Steensels S, Qiao J, Ersoy BA. (2020) Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. Metabolites. 10 |
| Steensels S, Qiao J, Zhang Y, et al. (2020) Acot9 traffics mitochondrial short-chain fatty acids towards de novo lipogenesis and glucose production in the liver. Hepatology (Baltimore, Md.) |
| Siljee JE, Wang Y, Bernard AA, et al. (2018) Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity. Nature Genetics |
| Ersoy BA, Maner-Smith KM, Li Y, et al. (2017) Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress. The Journal of Clinical Investigation |
| Kawano Y, Ersoy BA, Li Y, et al. (2014) Thioesterase superfamily member 2 (Them2) and phosphatidylcholine transfer protein (PC-TP) interact to promote fatty acid oxidation and control glucose utilization. Molecular and Cellular Biology. 34: 2396-408 |
| Ersoy BA, Tarun A, D'Aquino K, et al. (2013) Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling. Science Signaling. 6: ra64 |
| Ersoy BA, Pardo L, Zhang S, et al. (2012) Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR. Nature Chemical Biology. 8: 725-30 |
| Shishova EY, Stoll JM, Ersoy BA, et al. (2011) Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology (Baltimore, Md.). 54: 664-74 |
| Aslan IR, Ranadive SA, Ersoy BA, et al. (2011) Bariatric surgery in a patient with complete MC4R deficiency. International Journal of Obesity (2005). 35: 457-61 |
| Ranadive SA, Ersoy B, Favre H, et al. (2009) Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clinical Endocrinology. 71: 388-93 |